---

Coronavirus disease 2019 in diabetes: A pathophysiological linkage

---

Review Article

Author Details : Shreshtha Gaur, Surabhi Bajpai*, Sonal Gaur, Sonu Singhal, Rakesh Mishra

Volume : 9, Issue : 2, Year : 2022

Article Page : 92-97

https://doi.org/10.18231/j.ijcbr.2022.019

Suggest article by email

Get Permission

---

Abstract

Coronavirus disease 2019 (COVID-19) specifically in diabetic patients has attracted attention worldwide due to the poor prognosis of infection, compromised immunity and delayed response to medicines leading to increased death rate. Several pathophysiological explanations can be linked in support of connection between severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) alias COVID-19 and diabetes severity. In patients with diabetes, the innate immune system is compromised and the disease can be triggered by SARS-CoV-2. The exaggerated and inappropriate cytokine response can be evidenced in both diabetic and COVID-19 patients. This is evidenced by the elevated levels of IL-6 in their blood. It has been known that people with diabetes are more prone to having an inflammatory cytokine storm, which can cause acute respiratory distress syndrome (ARDS). Anti-viral drugs and agents can help lower blood sugar levels, but their use should be carefully monitored to see if they can also interact with COVID-19 treatment.

Keywords: Diabetes mellitus, Cytokine storm, NF­ B ?, p38 MAPK, COVID- 19.

How to cite : Gaur S, Bajpai S, Gaur S, Singhal S, Mishra R, Coronavirus disease 2019 in diabetes: A pathophysiological linkage. Int J Clin Biochem Res 2022;9(2):92-97

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.